KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Regeneron Pharmaceuticals (REGN) Change in Acquisitions & Divestments (2016 - 2025)

Historic Change in Acquisitions & Divestments for Regeneron Pharmaceuticals (REGN) over the last 17 years, with Q4 2025 value amounting to $2.6 billion.

  • Regeneron Pharmaceuticals' Change in Acquisitions & Divestments fell 104.57% to $2.6 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $11.5 billion, marking a year-over-year decrease of 2316.52%. This contributed to the annual value of $11.5 billion for FY2025, which is 2316.52% down from last year.
  • Per Regeneron Pharmaceuticals' latest filing, its Change in Acquisitions & Divestments stood at $2.6 billion for Q4 2025, which was down 104.57% from $3.4 billion recorded in Q3 2025.
  • Over the past 5 years, Regeneron Pharmaceuticals' Change in Acquisitions & Divestments peaked at $4.3 billion during Q3 2024, and registered a low of $318.0 million during Q4 2021.
  • Its 5-year average for Change in Acquisitions & Divestments is $2.2 billion, with a median of $2.2 billion in 2023.
  • In the last 5 years, Regeneron Pharmaceuticals' Change in Acquisitions & Divestments plummeted by 6666.81% in 2021 and then soared by 38345.91% in 2022.
  • Quarter analysis of 5 years shows Regeneron Pharmaceuticals' Change in Acquisitions & Divestments stood at $318.0 million in 2021, then skyrocketed by 383.46% to $1.5 billion in 2022, then skyrocketed by 55.0% to $2.4 billion in 2023, then grew by 8.36% to $2.6 billion in 2024, then decreased by 1.05% to $2.6 billion in 2025.
  • Its Change in Acquisitions & Divestments stands at $2.6 billion for Q4 2025, versus $3.4 billion for Q3 2025 and $2.2 billion for Q2 2025.